Efficacy and safety of mAbs anti-CGRP/CGRP R (eptinezumab and erenumab) or atogepant in combination with onabotulinumtoxinA in refractory chronic migraine: a clinical trial protocol.
Pain management
View this publicationPain management
View this publicationAIDS (London, England)
View this publicationMolecular medicine (Cambridge, Mass.)
View this publicationExperimental hematology
View this publicationThe Lancet. Rheumatology
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationOxidative medicine and cellular longevity
View this publicationCurrent opinion in neurobiology
View this publicationPloS one
View this publicationMolecular systems biology
View this publication